Skip to Main Content
Table 1

r-1,t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (trans, anti-PheT), r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene (trans, anti-BaP-tetraol), and 1-hydroxypyrene in urine

GroupMean ± SD (pmol/mg creatinine)a
trans, anti-PheTtrans, anti-BaP-tetraol (×10−3)1-hydroxypyrene
Psoriasis patients (n = 20) 791 ± 363 41.4 ± 40.9b 9,390 ± 10,600c 
Coke oven workers (n = 32) 25.7 ± 16.8 3.15 ± 3.04b 100 ± 62.0d 
Smokers (n = 31) 4.58 ± 2.95 N.A.e 1.33 ± 1.00 
Nonsmokers (n = 30) 1.51 ± 1.15 N.A. 0.58 ± 0.53 
GroupMean ± SD (pmol/mg creatinine)a
trans, anti-PheTtrans, anti-BaP-tetraol (×10−3)1-hydroxypyrene
Psoriasis patients (n = 20) 791 ± 363 41.4 ± 40.9b 9,390 ± 10,600c 
Coke oven workers (n = 32) 25.7 ± 16.8 3.15 ± 3.04b 100 ± 62.0d 
Smokers (n = 31) 4.58 ± 2.95 N.A.e 1.33 ± 1.00 
Nonsmokers (n = 30) 1.51 ± 1.15 N.A. 0.58 ± 0.53 
a

Differences in each analyte level among the groups were statistically significant, P < 0.0001.

b

From Ref. 27.

c

From Ref. 34.

d

From Ref. 35.

e

N.A., not analyzed.

Close Modal

or Create an Account

Close Modal
Close Modal